Filing Details
- Accession Number:
- 0001127602-19-027755
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-03 16:13:51
- Reporting Period:
- 2019-08-29
- Accepted Time:
- 2019-09-03 16:13:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1492422 | Apellis Pharmaceuticals Inc. | APLS | Pharmaceutical Preparations (2834) | 271537290 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1707000 | Eugene Timothy Sullivan | C/O Apellis Pharmaceuticals, Inc 6400 Westwind Way, Suite A Crestwood KY 40014 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-08-29 | 11,699 | $29.71 | 11,699 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Shares purchased through 10B5-1 trading plan. Purchase price range $29.34-$29.97.
Billionaire Hedge Funds
